BioCentury
ARTICLE | Company News

Oncomab, MEDX antibody deal

March 19, 2003 8:00 AM UTC

Medarex (MEDX) and Oncomab (Melbourne, Australia) will develop an antibody against an undisclosed tumor antigen from Oncomab. The antigen is expressed on the surface of solid tumors including breast, ...